Literature DB >> 12215248

Pre-counseling education materials for BRCA testing: does tailoring make a difference?

Celette Sugg Skinner1, Joellen M Schildkraut, Donald Berry, Brian Calingaert, P Kelly Marcom, Jeremy Sugarman, Eric P Winer, J Dirk Iglehart, P Andrew Futreal, Barbara K Rimer.   

Abstract

Although tailored print materials (TPMs) have been assessed for a variety of behavioral targets, their effectiveness as decision aids for genetic testing had not been evaluated at the time this study began. We compared TPMs and non-tailored print material (NPMs) that included similar content about genetic testing for breast and ovarian cancer susceptibility. TPMs were prepared especially for an individual based on information from and about her. We mailed baseline surveys to 461 women referred by physicians or identified through a tumor registry. All had personal and family histories of breast and/or ovarian cancer and, on the basis of these histories, an estimated > or =10% probability of carrying a mutation in the breast/ovarian cancer genes BRCA1 or BRCA2. The 325 (70%) who responded were randomly assigned to receive TPM or NPM. Followup surveys, mailed 2 weeks following receipt of print materials, were returned by 262 women (81% of baseline responders). Participants were predominately white (94%) and well-educated (50% college graduates). The mean age was 49 years. At follow-up, TPM recipients exhibited significantly greater improvement in percent of correct responses for the 13-item true/false measure of knowledge (24% increase for TPM vs. 16% for NPM; p < 0.0001) and significantly less over-estimation of risk of being a mutation carrier (40% TPM group overestimated vs. 70% NPM; p < 0.0001). Anxiety did not differ significantly between groups. Reactions to materials differed on two items: "seemed to be prepared just for me" (76% TPM vs. 52% NPM; p < 0.001) and "told me what I wanted to know about BRCA1 and 2 testing" (98% TPM vs. 91% NPM; p < 0.05). TPMs showed an advantage in increasing knowledge and enhancing accuracy of perceived risk. Both are critical components of informed decision making.

Entities:  

Mesh:

Year:  2002        PMID: 12215248     DOI: 10.1089/10906570260199348

Source DB:  PubMed          Journal:  Genet Test        ISSN: 1090-6576


  27 in total

1.  Genetic testing for BRCA1: effects of a randomised study of knowledge provision on interest in testing and long term test uptake; implications for the NICE guidelines.

Authors:  Julia Hall; Susan Gray; Roger A'Hern; Susan Shanley; Maggie Watson; Kathryn Kash; Robert Croyle; Rosalind Eeles
Journal:  Fam Cancer       Date:  2008-08-05       Impact factor: 2.375

2.  Classification of Missense Mutations of Disease Genes.

Authors:  Xi Zhou; Edwin S Iversen; Giovanni Parmigiani
Journal:  J Am Stat Assoc       Date:  2005       Impact factor: 5.033

Review 3.  Patient responses to genetic information: studies of patients with hereditary cancer syndromes identify issues for use of genetic testing in nephrology practice.

Authors:  Kimberly A Kaphingst; Colleen M McBride
Journal:  Semin Nephrol       Date:  2010-03       Impact factor: 5.299

4.  Use and evaluation of an individually tailored website for counselees prior to breast cancer genetic counseling.

Authors:  Akke Albada; Margreet G E M Ausems; Roel Otten; Jozien M Bensing; Sandra van Dulmen
Journal:  J Cancer Educ       Date:  2011-12       Impact factor: 2.037

5.  Enhanced counselling for women undergoing BRCA1/2 testing: Impact on knowledge and psychological distress-results from a randomised clinical trial.

Authors:  Pagona Roussi; Kerry Anne Sherman; Suzanne Miller; Joanne Buzaglo; Mary Daly; Alan Taylor; Eric Ross; Andrew Godwin
Journal:  Psychol Health       Date:  2010-04

6.  A pre-visit tailored website enhances counselees' realistic expectations and knowledge and fulfils information needs for breast cancer genetic counselling.

Authors:  Akke Albada; Sandra van Dulmen; Dick Lindhout; Jozien M Bensing; Margreet G E M Ausems
Journal:  Fam Cancer       Date:  2012-03       Impact factor: 2.375

7.  Impact of a primary care based intervention on breast cancer knowledge, risk perception and concern: A randomized, controlled trial.

Authors:  Jennifer Livaudais-Toman; Leah S Karliner; Jeffrey A Tice; Karla Kerlikowske; Steven Gregorich; Eliseo J Pérez-Stable; Rena J Pasick; Alice Chen; Jessica Quinn; Celia P Kaplan
Journal:  Breast       Date:  2015-10-21       Impact factor: 4.380

Review 8.  Personalised risk communication for informed decision making about taking screening tests.

Authors:  Adrian G K Edwards; Gurudutt Naik; Harry Ahmed; Glyn J Elwyn; Timothy Pickles; Kerry Hood; Rebecca Playle
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

9.  Development of E-info gene(ca): a website providing computer-tailored information and question prompt prior to breast cancer genetic counseling.

Authors:  Akke Albada; Sandra van Dulmen; Roel Otten; Jozien M Bensing; Margreet G E M Ausems
Journal:  J Genet Couns       Date:  2009-05-14       Impact factor: 2.537

10.  Genetic risk assessment for women with epithelial ovarian cancer: referral patterns and outcomes in a university gynecologic oncology clinic.

Authors:  Sue V Petzel; Rachel Isaksson Vogel; Tracy Bensend; Anna Leininger; Peter A Argenta; Melissa A Geller
Journal:  J Genet Couns       Date:  2013-05-16       Impact factor: 2.537

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.